FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 240+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

Kiyan Anthony, 18, followed in his father's footsteps when he announced his commitment to play for Syracuse basketball on ...

Your fingernails, as small as they are, can act as indicators of your overall health, offering subtle clues about potential ...

ORKA-001, targeting IL-23p19, Phase 1 trial dosing complete, with data expected in 3Q 2025 ORKA-001 Phase 2a initiation expected in 2H 2025, with efficacy readout expected in 2H 2026 that will provide ...

Remember the spine-chilling creatures from Stranger Things, The Mist, or A Quiet Place? What if we told you that something ...

The project, led by a team from the University of the West of England (UWE), aims to increase the visual representation of ...

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, dermatologic, ...

The time is now for a permanent halt to the naggingly recurring and seriously unhealthy chatter about Republicans raising the ...

Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing oral therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of ...

Alumis Inc. (Nasdaq: ALMS), a clinical-stage biopharmaceutical company developing therapies using a precision approach to optimize clinical outcomes and significantly improve the lives of patients ...

Q1 2025 Earnings Conference Call May 14, 2025 4:30 PM ETCompany ParticipantsJules Abraham - CORE IRDolev Rafaeli ...

MoonLake Immunotherapeutics Reports First Quarter 2025 Financial Results and Provides a Business Update Continued to make significant progress with the development of the Nanobody ®sonelokimab across ...